Skip to main content
Opens in new window
NHS Wales
NHS 111 Wales
Skip Navigation
Accessibility
Contact us
Cymraeg
Cymraeg
All...
Search
All Wales Therapeutics and Toxicology Centre
Search
Cymraeg
Cymraeg
Menu
Home
Accessing medicines
Medicines optimisation and safety
Show Submenu For Medicines optimisation and safety
Medicines optimisation guidance, resources and data
Yellow Card Centre Wales
Welsh National Poisons Unit
Sodium valproate information hub
Work in progress
News, meetings and events
Show Submenu For News, meetings and events
News
Meetings
Events
About us
Show Submenu For About us
Our committees
Who we are
What we do
Who we work with
Our research
Our reports and strategies
Sustainability
Contact us
More
×
NHS Wales
NHS 111 Wales
Accessibility
Contact us
All...
Search
Listen
Home
›
Files
›
Assessments (licensed) 2025 onwards: ESR, Recommendation and EqHIA
Assessments (licensed) 2025 onwards: ESR, Recommendation and EqHIA
29/05/2025
Recommendation and Decision Rationale: abiraterone 6441
29/05/2025
Equality and Health Impact Assessment: abiraterone 6441
29/05/2025
Evidence Summary Report: abiraterone 6441
29/05/2025
Recommendation and Decision Rationale: guanfacine (Intuniv) 6440
29/05/2025
Equality Health Impact Assessment: guanfacine (Intuniv) 6440
29/05/2025
Evidence Summary Report: guanfacine (Intuniv) 6440
Follow AWTTC:
